Regulatory
Manufacturing operations for API’s and related intermediates, whether at full scale or in the pilot plants, strictly adhere to cGMP as defined in the ICH Q7 Guideline “Good Manufacturing Practice” for Active Pharmaceutical Ingredients, recognized and accepted by the USA, EU and Japan.
The site is FDA registered and during the last two inspections, (November 2002 and September 2005) no 483 observations were issued. The Swedish regulatory agency, MPA (Medical Products Agency), performed a GMP inspection in November 2005 and a GMP certificate was issued. The facility is also certified according to ISO 9001.
Every year numerous customers and regulatory agencies conduct successful quality audits of our facilities. We ensure all of our employees undergo continuous training and remain dedicated to delivering the highest standards of maintaining cGMP, safety and environmental compliance. |